We are live on ! Find out more
NUTX icon

Nutex Health
NUTX

51 hedge funds and large institutions have $12M invested in Nutex Health in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 17 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more capital inflows, than outflows

Capital inflows: $6.78M | Capital outflows: $4.93M

0.11% more ownership

Funds ownership: 1.12% → 1.24% (+0.11%)

0% more funds holding

Funds holding: 51 → 51 (0)

0% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 10

12% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 17

Holders
51
Holders Change
–
Holders Change %
0%
% of All Funds
0.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
15
Reduced
17
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Creative Planning
Creative Planning
Kansas
+$2.32M
2
Millennium Management
Millennium Management
New York
+$1.42M
3
E
Ergoteles
New York
+$1.15M
4
Morgan Stanley
Morgan Stanley
New York
+$601K
5
State Street
State Street
Massachusetts
+$400K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$2.68M
2
Citadel Advisors
Citadel Advisors
Florida
-$839K
3
HRT Financial
HRT Financial
New York
-$477K
4
Banque Cantonale Vaudoise
Banque Cantonale Vaudoise
Switzerland
-$152K
5
Tudor Investment Corp
Tudor Investment Corp
Connecticut
-$149K

NUTX Hedge Fund Activity: Q3 2022 in Review

51 of the 5,832 institutional investors tracked by Wall St. Rank reported a position in Nutex Health (NUTX) for Q3 2022, worth a combined $12M — down 49% from $23.6M a quarter earlier.

Fund positioning in NUTX was balanced in Q3 2022: 10 funds opened new positions, 10 closed out, 15 added to existing stakes and 17 trimmed.

The largest buyer was Creative Planning, opening a new position worth an estimated $2.32M. The largest seller was Goldman Sachs, cutting an estimated $2.68M.

  • 51 institutional investors held Nutex Health (NUTX) as of Q3 2022, unchanged from Q2 2022.
  • Funds reported $12M of Nutex Health stock for Q3 2022, down 49% quarter-over-quarter.
  • 10 funds opened new Nutex Health positions in Q3 2022 and 10 closed out, a net change of 0 holders.
  • The largest Nutex Health buyer in Q3 2022 was Creative Planning, an estimated $2.32M added.
  • The largest Nutex Health seller in Q3 2022 was Goldman Sachs, an estimated $2.68M sold.

Based on aggregated 13F filings for Q3 2022.